Europe's Landmark Approval: Moderna's Combined Flu-COVID mRNA Vaccine Explained
Europe has taken a significant step in public health by being the first to authorize Moderna's innovative combination mRNA vaccine for both influenza and COVID-19. This approval marks a pivotal moment in vaccine development, promising enhanced convenience and protection for individuals.